Regions

The following classification of the documents is based on the geographical region to which these documents refer/apply to. Publications are available in HTML, PDF , DOC or XLS format. Click on the corresponding icon to open the publication.
Expand the sub-collections menu.
982 documents on 1 page
 
 
Open this document and view its content

El acceso a los medicamentos en el contexto del derecho de toda persona al disfrute del más alto nivel posible de salud física y mental. A/HRC/32/L.23/Rev.1, 30 de junio de 2016. Consejo de Derechos Humanos, 32º período de sesiones [Arabic] [Chinese] [English] [French] [Russian]

Year:

2016;

Pages:

6;


Regions:

 
Open this document and view its content

Access to Cancer Treatment: A Study of Medicine Pricing Issues with Recommendations for Improving Access to Cancer Medication

Year:

2015;

Pages:

54;

Related documents:

Regions:

 
Open this document and view its content

Access to Insulin: Current Challenges and Constraints. October 2015

Year:

2015;

Pages:

30;


Related documents:

Regions:

 
Open this document and view its content

Access to Medicines in the Context of the Right of Everyone to the Enjoyment of the Highest Attainable Standard of Physical and Mental Health. A/HRC/32/L.23/Rev.1, 30 June 2016. Human Rights Council, Thirty-second session [Arabic] [Chinese] [French] [Russian] [Spanish]

Year:

2016;

Pages:

5;


Regions:

 
Open this document and view its content

Access to Medicines in the Context of the Right of Everyone to the Enjoyment of the Highest Attainable Standard of Physical and Mental Health. A/HRC/32/L.23/Rev.1, 30 June 2016. Human Rights Council, Thirty-second session (Arabic version) الحصول على الأدوية في سياق حق كل فرد في التمتع بأعلى مستوى ممكن من الصحة البدنية والعقلية مجلس حقوق الإنسان الدورة الثانية والثلاثون [Chinese] [English] [French] [Russian] [Spanish]

Year:

2016;

Pages:

6;


Regions:

 
Open this document and view its content

Access to Medicines in the Context of the Right of Everyone to the Enjoyment of the Highest Attainable Standard of Physical and Mental Health. A/HRC/32/L.23/Rev.1, 30 June 2016. Human Rights Council, Thirty-second session (Chinese version) [Arabic] [English] [French] [Russian] [Spanish]

Year:

2016;

Pages:

5;


Regions:

 
Open this document and view its content

Access to Medicines in the Context of the Right of Everyone to the Enjoyment of the Highest Attainable Standard of Physical and Mental Health. A/HRC/32/L.23/Rev.1, 30 June 2016. Human Rights Council, Thirty-second session (Russian version) Доступ к лекарственным средствам в контексте права каждого человека на наивысший достижимый уровень физического и психического здоровья. A/HRC/32/L.23/Rev.1, 30 June 2016. Совет по правам человека, Тридцать вторая сессия [Arabic] [Chinese] [English] [French] [Spanish]

Year:

2016;

Pages:

7;


Regions:

 
Open this document and view its content

Access to Orphan Drugs: A Comprehensive Review of Legislations, Regulations and Policies in 35 Countries

Year:

2015;

Pages:

24;

Regions:

 
Open this document and view its content

L’accès aux médicaments dans le contexte du droit qu’a toute personne de jouir du meilleur état de santé physique et mentale possible. A/HRC/32/L.23/Rev.1, 30 juin 2016. Conseil des droits de l’homme, Trente-deuxième session [Arabic] [Chinese] [English] [Russian] [Spanish]

Year:

2016;

Pages:

6;


Regions:

 
Open this document and view its content

Addressing Resistance To Antibiotics In Pluralistic Health Systems

Year:

2015;

Pages:

24;

Related documents:

Regions:

 
Open this document and view its content

Alternative Regulatory Models for Pharmaceutical Promotions Involving Civil Society and Other Non-Government Stakeholders

Year:

2015;

Pages:

99;


Regions:

Countries:

 
Open this document and view its content

Analyzing Options for Strengthening Pharmaceutical Systems. January 2016

Year:

2016;

Pages:

94;


Related documents:

Regions:

 
Open this document and view its content

Antimicrobial Resistance: What Does Medicine Quality Have to Do with It?

Year:

2015;

Pages:

45;

Regions:

 
Open this document and view its content

Assistive Technology for Children with Disabilities: Creating Opportunities for Education, Inclusion and Participation. A discussion paper

Year:

2015;

Pages:

19;


Regions:

 
Open this document and view its content

Building Clinical Trials Capacity for Tuberculosis Drugs in High-Burden Countries

Year:

2007;

Pages:

4;

Regions:

 
Open this document and view its content

Call to Action: Combat Antimicrobial Resistance and Preserve Antimicrobials for Future Generations. May 2016

Year:

2016;

Pages:

4;


Regions:

 
Open this document and view its content

Clinical Trials Have Gone Global: Is This a Good Thing?

Year:

2012;

Pages:

5;

Related documents:

Regions:

 
Open this document and view its content

Commitments to Responsible Use of Antimicrobials in Humans. Meeting, Oslo, Norway, 13-14 November 2014 - Outcome Document

Year:

2014;

Pages:

4;


Regions:

 
Open this document and view its content

Continuing Pharmaceutical Education: Guide to Establishing Quality Assured and Accredited Programs

Year:

2016;

Pages:

89;


Related documents:

Regions:

 
Open this document and view its content

Convention on Psychotropic Substances, 1971. (Including Final Act and Resolutions, as agreed by the 1971 United Nations Conference for the Adoption of a Protocol on Psychotropic Substances, and the Schedules annexed to the Convention) - (Russian version) КОНВЕНЦИЯ О ПСИХОТРОПНЫХ ВЕЩЕСТВАХ 1971 ГОДА. с Заключительным актом и резолюциями, утвержденными Конференцией Организации Объединенных Наций для при-нятия Протокола о психотропных веществах, и списками веществ, прилагаемыми к настоящей Конвенции [Arabic] [Chinese] [English] [French] [Spanish]

Year:

1971;

Pages:

42;


Regions:

 
Open this document and view its content

Corruption in the pharmaceutical sector. Diagnosing the challenges

Year:

2016;

Pages:

58;


Regions:

 
Open this document and view its content

Cross-Sectional Pilot Study to Monitor the Availability, Dispensed Prices, and Affordability of Opioids Around the Globe

Year:

2014;

Pages:

12;

Related documents:

Regions:

 
Open this document and view its content

Decreasing the Data Burden at the Last Mile to Improve Data Management and Use for Stronger Pharmaceutical Systems

Year:

2015;

Pages:

20;


Regions:

Countries:

 
Open this document and view its content

Defining and Measuring Pharmaceutical Systems Strengthening: Report of the SIAPS Partners’ Consultative Meeting. September 11-12, 2014

Year:

2014;

Pages:

72;


Regions:

 
Open this document and view its content

Developing Socially Responsible Intellectual Property Licensing Policies: Non-exclusive Licensing Initiatives in the Pharmaceutical Sector. (Research Handbook on Intellectual Property Licensing, Chapter 10)

Year:

2013;

Pages:

32;

Related documents:

Regions:

 
Open this document and view its content

Development of a Risk-Based Approach and Tools for Improving Safe and Rational Use of Tuberculosis Medicines

Year:

2013;

Pages:

40;


Regions:

 
Open this document and view its content

Drug Utilization Studies : Methods and Uses

Year:

1993;

Pages:

221;

Regions:

 
Open this document and view its content

Evaluating Availability and Price of Essential Medicines in Boston Area (Massachusetts, USA) Using WHO/HAI Methodology. (With Additional File 1: Supplementary Details on Survey Methods, Data and Statistical Analyses)

Year:

2016;

Pages:

47;

Regions:

 
Open this document and view its content

Farmacovigilancia, hacia una mayor seguridad en el uso de medicamentos - 2012

Year:

2012;

Pages:

329;


 
Open this document and view its content

FIP–WHO Technical Guidelines: Points to Consider in the Provision by Health-care Professionals of Children-specific Preparations That Are Not Available as Authorized Products. WHO Technical Report Series, No. 996, 2016, Annex 2

Year:

2016;

Pages:

24;


Related documents:

Regions:

 
Open this document and view its content

Global Atlas of Palliative Care at the End of Life

Year:

2014;

Pages:

111;


Related documents:

Regions:

 
Open this document and view its content

The Global Intellectual Property Ecosystem for Insulin and Its Public Health Implications: An Observational Study

Year:

2016;

Pages:

9;

Related documents:

Regions:

 
Open this document and view its content

Guidance for Planning the Introduction of New Reproductive, Maternal, Newborn, and Child Health Medicines and Supplies. March 2016

Year:

2016;

Pages:

78;


Related documents:

Regions: